Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2015

Feb 26, 2015

31971_dirs_2015-02-26_187f6fd8-0c41-4e78-b341-e8e66b25d208.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2015-02-23

Reporting Person: Hartman Curt R (President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-02-23 Common Stock M 2709 Acquired 21887 Direct
2015-02-23 Common Stock F 1358 $51.75 Disposed 20529 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-02-23 Rsus (restricted Stock Units) $0 M 2709 Disposed Common Stock (2709) Direct
2015-02-24 Rsus (restricted Stock Units) $0 D 13542 Disposed Common Stock (13542) Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company"), and is subject to the terms and conditions of the Company's 2006 Stock Incentive Plan. Under the terms of Mr. Hartman's offer letter, dated July 22, 2014, in connection with his appointment as Interim CEO, the total number of RSUs granted were to vest in 1/12 increments until the one time PSU award granted February 24, 2015, as disclosed in the 8-K filed November 10, 2014. This is the final increment awarded to Mr. Hartman under the terms of the July 22, 2014 offer letter.